NCT04664829 2025-09-23
The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC
National Cancer Centre, Singapore
Phase 1 Completed
Clinical Trials
4 trialsNCT03323658 2023-01-10
Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003752 2013-05-30
Bexarotene in Treating Patients With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00055991 2013-02-05
Bexarotene in Preventing Breast Cancer in Women at Genetic Risk
Baylor Breast Care Center
Phase 1 Completed